Evidence map›Paper›PMID 22897585›Full record

ArticleJournal of proteome research2012

Rat mammary extracellular matrix composition and response to ibuprofen treatment during postpartum involution by differential GeLC-MS/MS analysis.

Jenean H O'Brien, Lauren A Vanderlinden, Pepper J Schedin, Kirk C Hansen

Abstract read
In one paragraph

Article in Journal of proteome research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. The Mammary Tumor Microenvironment.Advances in experimental medicine and biology · 2020
    Article
  8. Article
  9. Article
  10. Porcine Breast Extracellular Matrix Hydrogel for Spatial Tissue Culture.International journal of molecular sciences · 2018
    Article
  11. Article
  12. Mucosal Immunity in the Female Murine Mammary Gland.Journal of immunology (Baltimore, Md. : 1950) · 2018
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Jenean H O'BrienSchool of Medicine, Division of Medical Oncology, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado, United States.
Lauren A Vanderlinden
Pepper J Schedin
Kirk C Hansen
Cancer Research Center · USUniversity of Colorado Cancer Center · USUniversity of Colorado Denver · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025780 · NCRR · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2008 to 2011
$61.3M
LTQ Orbitrap Mass Spectrometer RequestS10RR024599 · NCRR · UNIVERSITY OF COLORADO DENVER · PI HANSEN, KIRK C · 2009 to 2009
$500k
Methods for the Analysis of Tumor Extracellular MatrixR21CA132741 · NCI · UNIVERSITY OF COLORADO DENVER · PI HANSEN, KIRK C · 2010 to 2011
$361k
NCI NIH HHS P30 CA046934NCI NIH HHS R21 CA132741NCI NIH HHS R21CA132741NCRR NIH HHS S10 RR024599NCRR NIH HHS UL1 RR025780
6 · The paper itself

Abstract

Breast cancer patients diagnosed within five years following pregnancy have increased metastasis and decreased survival. A hallmark of postpartum biology that may contribute to this poor prognosis is mammary gland involution, involving massive epithelial cell death and dramatic stromal remodeling. Previous studies show pro-tumorigenic properties of extracellular matrix (ECM) isolated from rodent mammary glands undergoing postpartum involution. More recent work demonstrates systemic ibuprofen treatment during involution decreases its tumor-promotional nature. Utilizing a proteomics approach, we identified relative differences in the composition of mammary ECM isolated from nulliparous rats and those undergoing postpartum involution, with and without ibuprofen treatment. GeLC-MS/MS experiments resulted in 20327 peptide identifications that mapped to 884 proteins with a <0.02% false discovery rate. Label-free quantification yielded several ECM differences between nulliparous and involuting glands related to collagen-fiber organization, cell motility and attachment, and cytokine regulation. Increases in known pro-tumorigenic ECM proteins osteopontin, tenascin-C, and laminin-α1 and pro-inflammatory proteins STAT3 and CD68 further identify candidate mediators of breast cancer progression specific to the involution window. With postpartum ibuprofen treatment, decreases in tenascin-C and three laminin chains were revealed. Our data suggest novel ECM mediators of breast cancer progression and demonstrate a protective influence of ibuprofen on mammary ECM composition.

Indexed as

AnimalsBasement MembraneCells, CulturedCyclooxygenase InhibitorsExtracellular MatrixExtracellular Matrix ProteinsFemaleIbuprofenLamininMammary Glands, AnimalPostpartum PeriodProtein Interaction MapsRatsRats, Sprague-DawleySpectrometry, Mass, Electrospray IonizationTandem Mass SpectrometryCyclooxygenase InhibitorsExtracellular Matrix ProteinsIbuprofenLaminin

Identifiers

PMID22897585
PMCPMC4292908
OpenAlexW2328435375

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.